Working With Your State Opioid Treatment Authority

An opioid treatment program (OTP) has three regulators that matter every day: SAMHSA, DEA and the state. The state's voice is the State Opioid Treatment Authority (SOTA). Part 8 defines it as "the agency designated by the Governor of a State, or other appropriate official designated by the Governor, to exercise the responsibility and authority within the State or Territory for governing the treatment of OUD with MOUD in OTPs" (42 CFR 8.2). In some states the SOTA is a division of the behavioral health agency that also licenses the program; in others the license comes from a different department.

What does the SOTA do in federal OTP oversight?

Part 8 gives the state authority a role at several points:

• Certification. SAMHSA grants or renews certification only "after consultation with the appropriate State authority regarding the qualifications of the applicant" (42 CFR 8.11(c)(1)). SAMHSA's FAQ adds that it "will not grant provisional certification without state and DEA approvals."
• Interim treatment. An OTP needs approval from both SAMHSA and the SOTA before it offers interim treatment, and SAMHSA needs documentation from the SOTA that it does not object and that comprehensive treatment is not available nearby within 14 days (8.11(f)). The program then notifies the SOTA when each patient starts, leaves and is about to transfer (8.12(j)(2)). See interim treatment for up to 180 days.
• Exemptions. SAMHSA "shall consult with the appropriate State authority prior to taking action on an exemption request" from the Part 8 standards (8.11(g)).
• Minors. Outside states that let minors consent on their own, a person under 18 may be admitted only with written consent from a parent, legal guardian or "responsible adult designated by the relevant State authority" (8.12(e)(2)).
• State law generally. Part 8 does not "limit the authority of State and, as appropriate, local governmental entities to regulate the use of MOUD" (8.11(e)(1)), and medication units "shall comply with all pertinent State laws and regulations" (8.11(h)(1)).

SAMHSA's own guidance sends applicants to the state first: "Find more information about individual state regulations by contacting your State Opioid Treatment Authority."

How does state law add to the SOTA's role?

Many states write the SOTA into their own law, which turns its approval into a license condition. Two examples from rules we have read:

• Oregon: "No person or governmental entity shall operate an Opioid Treatment Program (OTP) without a letter of approval from the State Opioid Treatment Authority in Oregon" (Or. Admin. R. 415-020-0010(1)), on top of the state's behavioral health certificate.
• West Virginia: the OTP licensing article has its own section on the State Opioid Treatment Authority (W. Va. Code 16B-13-11), alongside the license requirement and the moratorium on new programs.

State gates such as certificates of need and need reviews usually sit with the licensing agency rather than the SOTA, but the two offices talk. Our post on certificate of need and need review for new OTPs covers those.

How do you find the right office?

Start with SAMHSA's SOTA page, which lists a contact for each state, the District of Columbia, Puerto Rico and the U.S. Virgin Islands. Then check it, because some entries are out of date or incomplete:

• Several entries list only a person, an address and an email, with no agency named.
• Oregon's entry names the Addictions and Mental Health Division, while the Oregon Health Authority now runs the program.
• Ohio's entry uses the department's former name; the agency is now the Ohio Department of Behavioral Health.
• Missouri's entry carries a Mississippi zip code.

Our state pages show the SOTA as SAMHSA lists it, flag the stale entries, and give the state license and any need review we have verified from the state's own law. When the list and the state's website disagree, call the state.

Where should the first conversation start?

1. Ask about gates before anything else. Certificate of need, need review, moratorium, local notice or zoning steps, or an application window. Georgia's licensing agency, for example, accepts new narcotic treatment program applications only during announced open enrollment.
2. Ask which state approvals SAMHSA and DEA will look for. DEA's NTP Manual says its pre-registration investigation includes "verification of state licensure with SOTA." Know exactly which state document satisfies that.
3. Ask about state rules stricter than Part 8. States can set their own take-home, staffing, dosing-hour or medication unit rules. Pennsylvania's narcotic treatment program rules, as published, state: "Narcotic treatment medication units are prohibited" (28 Pa. Code 715.25).
4. Share your timeline in writing. A short summary of the program sponsor, medical director, address, capacity and planned opening date makes the SOTA's consultation with SAMHSA faster and avoids surprises.

Which changes should the SOTA hear about?

Federal rules require SAMHSA notice within three weeks of a new program sponsor or medical director (8.11(e)(5)), and DEA will not approve an NTP address change "without the proper authorizations from the SOTA and SAMHSA," according to DEA's NTP Manual. Many states have their own notice rules for the same events, plus ownership changes, new medication units and closures. Treat the SOTA as the third recipient of every significant change, and check the state rule for its deadline. See changing program sponsor or medical director.

How do we help?

We are not affiliated with any State Opioid Treatment Authority. Our Opioid Treatment Program Approval Package ($6,995 plus the state license package) includes the state side: identifying the authority and the licensing agency, confirming any gate, preparing the state license file and coordinating the state approval that SAMHSA and DEA look for. Owners and officers sign the state forms, and the program pays every state fee directly. See the OTP approval hub and pricing.